Yaghoobi H - Search Results

1

CRISPR/Cas9 as precision and high-throughput genetic engineering tools in gastrointestinal cancer research and therapy.

Hosseini SA, Salehifard Jouneghani A, Ghatrehsamani M, Yaghoobi H, Elahian F, Mirzaei SA. Hosseini SA, et al. Among authors: yaghoobi h. Int J Biol Macromol. 2022 Dec 31;223(Pt A):732-754. doi: 10.1016/j.ijbiomac.2022.11.018. Epub 2022 Nov 11. Int J Biol Macromol. 2022. PMID: 36372102 Review.

2

Designed miR-19a/b sponge induces apoptosis in lung cancer cells through the PI3K-PTEN-Akt pathway regulation.

Hosseini SA, Seidi M, Yaghoobi H. Hosseini SA, et al. Among authors: yaghoobi h. Mol Biol Rep. 2022 Sep;49(9):8485-8493. doi: 10.1007/s11033-022-07670-0. Epub 2022 Jun 29. Mol Biol Rep. 2022. PMID: 35767105

3

Investigation of the therapeutic role of native plant compounds against colorectal cancer based on system biology and virtual screening.

Alibakhshi A, Malekzadeh R, Hosseini SA, Yaghoobi H. Alibakhshi A, et al. Among authors: yaghoobi h. Sci Rep. 2023 Jul 15;13(1):11451. doi: 10.1038/s41598-023-38134-5. Sci Rep. 2023. PMID: 37454152 Free PMC article.

4

A comprehensive review of cancer therapies mediated by conjugated gold nanoparticles with nucleic acid.

Hosseini SA, Kardani A, Yaghoobi H. Hosseini SA, et al. Among authors: yaghoobi h. Int J Biol Macromol. 2023 Dec 31;253(Pt 5):127184. doi: 10.1016/j.ijbiomac.2023.127184. Epub 2023 Oct 3. Int J Biol Macromol. 2023. PMID: 37797860 Review.

5

Herbal Medicines as Potential Inhibitors of SARS-CoV-2 Infection.

Rostami S, Gharibi S, Yaghoobi H, Nokhodian Z, Shoaei P, Bahrami AA, Ahangarzadeh S, Alibakhshi A. Rostami S, et al. Among authors: yaghoobi h. Curr Pharm Des. 2022;28(29):2375-2386. doi: 10.2174/1381612828666220802121014. Curr Pharm Des. 2022. PMID: 35927924 Review.

6

Targeted cancer therapy through antibody fragments-decorated nanomedicines.

Alibakhshi A, Abarghooi Kahaki F, Ahangarzadeh S, Yaghoobi H, Yarian F, Arezumand R, Ranjbari J, Mokhtarzadeh A, de la Guardia M. Alibakhshi A, et al. Among authors: yaghoobi h. J Control Release. 2017 Dec 28;268:323-334. doi: 10.1016/j.jconrel.2017.10.036. Epub 2017 Nov 5. J Control Release. 2017. PMID: 29107128 Review.

7

MiR-548k suppresses apoptosis in breast cancer cells by affecting PTEN/PI3K/AKT signaling pathway.

Yadollahi-Farsani M, Amini-Farsani Z, Moayedi F, Khazaei N, Yaghoobi H. Yadollahi-Farsani M, et al. Among authors: yaghoobi h. IUBMB Life. 2023 Feb;75(2):97-116. doi: 10.1002/iub.2688. Epub 2022 Dec 24. IUBMB Life. 2023. PMID: 36309967 Free article.

8

MiR-548 K regulatory effect on the ABCG2 gene expression in MDR breast cancer cells.

Saberiyan M, Ghasemi Z, Yaghoobi H. Saberiyan M, et al. Among authors: yaghoobi h. Cancer Rep (Hoboken). 2023 Jun;6(6):e1816. doi: 10.1002/cnr2.1816. Epub 2023 May 11. Cancer Rep (Hoboken). 2023. PMID: 37166017 Free PMC article.

9

Inhibition of miR-155 in MCF-7 breast cancer cell line by gold nanoparticles functionalized with antagomir and AS1411 aptamer.

Kardani A, Yaghoobi H, Alibakhshi A, Khatami M. Kardani A, et al. Among authors: yaghoobi h. J Cell Physiol. 2020 Oct;235(10):6887-6895. doi: 10.1002/jcp.29584. Epub 2020 Jan 31. J Cell Physiol. 2020. PMID: 32003016

10

Assessment of expression of interferon γ (IFN-G) gene and its antisense (IFNG-AS1) in breast cancer.

Yaghoobi H, Azizi H, Oskooei VK, Taheri M, Ghafouri-Fard S. Yaghoobi H, et al. World J Surg Oncol. 2018 Oct 18;16(1):211. doi: 10.1186/s12957-018-1508-1. World J Surg Oncol. 2018. PMID: 30336781 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters